PT  - JOURNAL ARTICLE
AU  - Weber, Jeffrey
AU  - Grob, Jean-Jaques
AU  - Margolin, Kim A
AU  - Ascierto, Paolo A
AU  - Sznol, Mario
AU  - Ott, Patrick A
AU  - Lejeune, Chantal
AU  - de Pril, Veerle
AU  - Ruisi, Mary M
AU  - Hodi, F Stephen
TI  - A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence
AID  - 10.1186/2051-1426-3-S2-P166
DP  - 2015 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - P166
VI  - 3
IP  - Suppl 2
4099  - http://jitc.bmj.com/content/3/Suppl_2/P166.short
4100  - http://jitc.bmj.com/content/3/Suppl_2/P166.full
SO  - J Immunother Cancer2015 Dec 01; 3